Alphabetic Index | Tabular List | Neoplasms | Drugs and Chemicals | Injuries
T80
Complications following infusion, transfusion and therapeutic injection
T80.0
Air embolism following infusion, transfusion and therapeutic injection
T80.1
Vascular complications following infusion, transfusion and therapeutic injection
  • extravasation of vesicant agent (T80.81-)
  • infiltration of vesicant agent (T80.81-)
  • vascular complications specified as due to prosthetic devices, implants and grafts (T82.8-, T83.8-, T84.8-, T85.8-)
  • postprocedural vascular complications (T81.7-)
T80.2
Infections following infusion, transfusion and therapeutic injection
  • infections specified as due to prosthetic devices, implants and grafts (T82.6-T82.7, T83.5-T83.6, T84.5-T84.7, T85.7)
  • postprocedural infections (T81.4-)
T80.21
Infection due to central venous catheter
  • Infection due to pulmonary artery catheter (Swan-Ganz catheter)
T80.211
Bloodstream infection due to central venous catheter
  • Catheter-related bloodstream infection (CRBSI) NOS
  • Central line-associated bloodstream infection (CLABSI)
  • Bloodstream infection due to Hickman catheter
  • Bloodstream infection due to peripherally inserted central catheter (PICC)
  • Bloodstream infection due to portacath (port-a-cath)
  • Bloodstream infection due to pulmonary artery catheter
  • Bloodstream infection due to triple lumen catheter
  • Bloodstream infection due to umbilical venous catheter
T80.212
Local infection due to central venous catheter
  • Exit or insertion site infection
  • Local infection due to Hickman catheter
  • Local infection due to peripherally inserted central catheter (PICC)
  • Local infection due to portacath (port-a-cath)
  • Local infection due to pulmonary artery catheter
  • Local infection due to triple lumen catheter
  • Local infection due to umbilical venous catheter
  • Port or reservoir infection
  • Tunnel infection
T80.218
Other infection due to central venous catheter
  • Other central line-associated infection
  • Other infection due to Hickman catheter
  • Other infection due to peripherally inserted central catheter (PICC)
  • Other infection due to portacath (port-a-cath)
  • Other infection due to pulmonary artery catheter
  • Other infection due to triple lumen catheter
  • Other infection due to umbilical venous catheter
T80.219
Unspecified infection due to central venous catheter
  • Central line-associated infection NOS
  • Unspecified infection due to Hickman catheter
  • Unspecified infection due to peripherally inserted central catheter (PICC)
  • Unspecified infection due to portacath (port-a-cath)
  • Unspecified infection due to pulmonary artery catheter
  • Unspecified infection due to triple lumen catheter
  • Unspecified infection due to umbilical venous catheter
T80.22
Acute infection following transfusion, infusion, or injection of blood and blood products
T80.29
Infection following other infusion, transfusion and therapeutic injection
T80.3
ABO incompatibility reaction due to transfusion of blood or blood products
  • minor blood group antigens reactions (Duffy) (E) (K) (Kell) (Kidd) (Lewis) (M) (N) (P) (S) (T80.A-)
T80.30
ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
  • ABO incompatibility blood transfusion NOS
  • Reaction to ABO incompatibility from transfusion NOS
T80.31
ABO incompatibility with hemolytic transfusion reaction
T80.310
ABO incompatibility with acute hemolytic transfusion reaction
  • ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion
  • Acute hemolytic transfusion reaction (AHTR) due to ABO incompatibility
T80.311
ABO incompatibility with delayed hemolytic transfusion reaction
  • ABO incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion
  • Delayed hemolytic transfusion reaction (DHTR) due to ABO incompatibility
T80.319
ABO incompatibility with hemolytic transfusion reaction, unspecified
  • ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion
  • Hemolytic transfusion reaction (HTR) due to ABO incompatibility NOS
T80.39
Other ABO incompatibility reaction due to transfusion of blood or blood products
  • Delayed serologic transfusion reaction (DSTR) from ABO incompatibility
  • Other ABO incompatible blood transfusion
  • Other reaction to ABO incompatible blood transfusion
T80.4
Rh incompatibility reaction due to transfusion of blood or blood products
  • Reaction due to incompatibility of Rh antigens (C) (c) (D) (E) (e)
T80.40
Rh incompatibility reaction due to transfusion of blood or blood products, unspecified
  • Reaction due to Rh factor in transfusion NOS
  • Rh incompatible blood transfusion NOS
T80.41
Rh incompatibility with hemolytic transfusion reaction
T80.410
Rh incompatibility with acute hemolytic transfusion reaction
  • Acute hemolytic transfusion reaction (AHTR) due to Rh incompatibility
  • Rh incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion
T80.411
Rh incompatibility with delayed hemolytic transfusion reaction
  • Delayed hemolytic transfusion reaction (DHTR) due to Rh incompatibility
  • Rh incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion
T80.419
Rh incompatibility with hemolytic transfusion reaction, unspecified
  • Rh incompatibility with hemolytic transfusion reaction at unspecified time after transfusion
  • Hemolytic transfusion reaction (HTR) due to Rh incompatibility NOS
T80.49
Other Rh incompatibility reaction due to transfusion of blood or blood products
  • Delayed serologic transfusion reaction (DSTR) from Rh incompatibility
  • Other reaction to Rh incompatible blood transfusion
T80.A
Non-ABO incompatibility reaction due to transfusion of blood or blood products
  • Reaction due to incompatibility of minor antigens (Duffy) (Kell) (Kidd) (Lewis) (M) (N) (P) (S)
T80.A0
Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
  • Non-ABO antigen incompatibility reaction from transfusion NOS
T80.A1
Non-ABO incompatibility with hemolytic transfusion reaction
T80.A10
Non-ABO incompatibility with acute hemolytic transfusion reaction
  • Acute hemolytic transfusion reaction (AHTR) due to non-ABO incompatibility
  • Non-ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion
T80.A11
Non-ABO incompatibility with delayed hemolytic transfusion reaction
  • Delayed hemolytic transfusion reaction (DHTR) due to non-ABO incompatibility
  • Non-ABO incompatibility with hemolytic transfusion reaction 24 or more hours after transfusion
T80.A19
Non-ABO incompatibility with hemolytic transfusion reaction, unspecified
  • Hemolytic transfusion reaction (HTR) due to non-ABO incompatibility NOS
  • Non-ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion
T80.A9
Other non-ABO incompatibility reaction due to transfusion of blood or blood products
  • Delayed serologic transfusion reaction (DSTR) from non-ABO incompatibility
  • Other reaction to non-ABO incompatible blood transfusion
T80.5
Anaphylactic reaction due to serum
  • ABO incompatibility reaction due to transfusion of blood or blood products (T80.3-)
  • allergic reaction or shock NOS (T78.2)
  • anaphylactic reaction or shock NOS (T78.2)
  • anaphylactic reaction or shock due to adverse effect of correct medicinal substance properly administered (T88.6)
  • other serum reaction (T80.6-)
  • Allergic shock due to serum
  • Anaphylactic shock due to serum
  • Anaphylactoid reaction due to serum
  • Anaphylaxis due to serum
T80.51
Anaphylactic reaction due to administration of blood and blood products
T80.52
Anaphylactic reaction due to vaccination
T80.59
Anaphylactic reaction due to other serum
T80.6
Other serum reactions
  • serum hepatitis (B16-B19)
  • Intoxication by serum
  • Protein sickness
  • Serum rash
  • Serum sickness
  • Serum urticaria
T80.61
Other serum reaction due to administration of blood and blood products
T80.62
Other serum reaction due to vaccination
T80.69
Other serum reaction due to other serum
  • , if applicable, arthropathy in hypersensitivity reactions classified elsewhere (M36.4)
T80.8
Other complications following infusion, transfusion and therapeutic injection
T80.81
Extravasation of vesicant agent
  • Infiltration of vesicant agent
T80.810
Extravasation of vesicant antineoplastic chemotherapy
  • Infiltration of vesicant antineoplastic chemotherapy
T80.818
Extravasation of other vesicant agent
  • Infiltration of other vesicant agent
T80.89
Other complications following infusion, transfusion and therapeutic injection
  • Delayed serologic transfusion reaction (DSTR), unspecified incompatibility
T80.9
Unspecified complication following infusion, transfusion and therapeutic injection
T80.90
Unspecified complication following infusion and therapeutic injection
T80.91
Hemolytic transfusion reaction, unspecified incompatibility
  • ABO incompatibility with hemolytic transfusion reaction (T80.31-)
  • Non-ABO incompatibility with hemolytic transfusion reaction (T80.A1-)
  • Rh incompatibility with hemolytic transfusion reaction (T80.41-)
T80.910
Acute hemolytic transfusion reaction, unspecified incompatibility
T80.911
Delayed hemolytic transfusion reaction, unspecified incompatibility
T80.919
Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed
  • Hemolytic transfusion reaction NOS
T80.92
Unspecified transfusion reaction
  • Transfusion reaction NOS